• Immunotherapies improve long-term disability outcomes in MS

    8 days ago - By Healio

    Long-term exposure to immunotherapy reduced the rate of relapses and disability progression among a large cohort of patients with MS followed for 15 years, according to findings published in Neurology.
    “A proof of long-term effect of immunomodulation on the accumulation of MS-related neurological disability is the key to establishing its disease modifying properties,” Tomas Kalincik, MD, PhD, a principal research fellow in neurological outcomes at Royal Melbourne Hospital, and colleagues wrote. “Here we present a study from the largest international MS registry, whose aim was
    Read more ...